Leap Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.7%.

Top 25 shareholders own 56.85% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.9%	Gilead Sciences, Inc.	5,319,148	US$19.7m	0%	no data
8.1%	Balyasny Asset Management L.P.	3,100,000	US$11.5m	362%	0.03%
6.38%	Samsara BioCapital LLC	2,442,352	US$9.1m	265%	1.04%
3.4%	683 Capital Management, LLC	1,300,000	US$4.8m	189%	0.42%
3.31%	Rock Springs Capital Management LP	1,266,546	US$4.7m	38.9%	0.13%
3.18%	BeiGene, Ltd.	1,215,306	US$4.5m	65.4%	no data
3.06%	Baker Bros. Advisors LP	1,172,175	US$4.3m	0%	0.04%
2.6%	The Vanguard Group, Inc.	996,235	US$3.7m	14.8%	no data
2.4%	Citadel Advisors LLC	918,106	US$3.4m	29.1%	no data
1.85%	Laurion Capital Management LP	709,219	US$2.6m	0%	0.08%
1.77%	HealthCare Ventures LLC	676,320	US$2.5m	0%	100.0%
1.65%	Simplify Asset Management Inc.	631,269	US$2.3m	67.9%	0.17%
0.84%	Key Client Fiduciary Advisors, LLC	321,923	US$1.2m	13%	0.52%
0.73%	Geode Capital Management, LLC	279,097	US$1.0m	37.8%	no data
0.67%	Acadian Asset Management LLC	256,655	US$952.2k	-9.12%	no data
0.51%	Acuta Capital Partners, LLC	195,000	US$723.4k	-44.9%	0.47%
0.45%	BlackRock, Inc.	172,056	US$638.3k	487%	no data
0.39%	UBS O'Connor LLC	149,772	US$555.7k	39.4%	0.04%
0.3%	Knott Partners Management, LLC	114,355	US$424.3k	0%	0.19%
0.3%	Adage Capital Management, L.P.	113,743	US$422.0k	-76.3%	no data
0.26%	Renaissance Technologies LLC	97,670	US$362.4k	-14.7%	no data
0.21%	HANSAINVEST Hanseatische Investment-GmbH	81,000	US$300.5k	50%	0.02%
0.21%	Marshall Wace LLP	79,758	US$295.9k	268%	no data
0.19%	Douglas Onsi	73,646	US$273.2k	0%	no data
0.19%	State Street Global Advisors, Inc.	71,813	US$266.4k	13.6%	no data